delivers an efficient and accountable digital media + direct relationship management platform with the unique ability to enable hospitals to build physician practices, grow admissions, differentiate their brands, and improve the health of their populations.
Saturday, October 24, 2015
Arenavirus Infection Lassa Fever Pipeline Review, H2 2015 - 3 Companies & 9 Drug profiles
. Buy Fruits & Berries online Buy Flonase (Fluticasone) with free prescription DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/k3mkf5/arenavirus)
has announced the addition of the "Arenavirus
Infection Lassa Fever - Pipeline Review, H2 2015" report to
their offering.
This report provides comprehensive information on the therapeutic
development for Arenavirus Infection Lassa Fever, complete with
comparative analysis at various stages, therapeutics assessment by drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type, along with latest updates, and featured news and press
releases. http://asthmareview.wordpress.com Headway without prescription Diflucan (Fluconazole) with no Rx It also reviews key players involved in the therapeutic
development for Arenavirus Infection Lassa Fever and special features on
late-stage and discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. About Desogen (Desogestrel / Ethinyl estradiol) with free Rx Buy Retrovir (Zidovudine) without Rx It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Companies Involved in Therapeutics Development
Etubics Corporation
Profectus BioSciences, Inc.
SIGA Technologies, Inc.
Drug Profiles
DEF-201
FBH-003
FDX-000
lassa fever vaccine
lassa fever vaccine 1
lassa fever vaccine 2
Monoclonal Antibodies for Viral Infections
Small Molecules to Inhibit NPC1 for Ebola and Lassa Fever Virus
ST-161
For more information visit .researchandmarkets.com/research/k3mkf5/arenavirus
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment